Genelux GNLX
NASDAQ GNLX
$2.48 -0.04 (-1.59%)
At close: Sep 10, 2026 · 4:00 PM EDT

Genelux (GNLX) EPS (Basic) (2022 - 2026)

Genelux (GNLX) posted EPS (Basic) of -$0.2 for Q1 2026, up 18.39% on a QoQ basis from -$0.25 in Q4 2025, and up 6.74% year-over-year from -$0.19 in Q1 2025.

Analysis

Genelux (GNLX) EPS (Basic) (2022 - 2026) Analysis & Trends

Genelux has reported EPS (Basic) for 5 years, with the latest figure at -$0.2 in Q1 2026.

  • On a quarterly basis, EPS (Basic) rose 6.74% year-over-year to -$0.2 in Q1 2026; TTM through Mar 2026 was -$0.77, a 12.52% increase from a year earlier, with the FY2025 full-year figure at -$0.87, up 11.29% from the prior year.
  • EPS (Basic) was -$0.2 for Q1 2026 at Genelux, up from -$0.25 in the prior quarter.
  • The five-year high for EPS (Basic) was $0.54 in Q3 2022, with the low at -$0.49 in Q1 2023.
  • Average EPS (Basic) over 5 years is -$0.21, with a median of -$0.22 recorded in 2025.
  • The sharpest annual moves came in 2023 and 2024: EPS (Basic) sank 137.88% in 2023, then jumped 40.21% in 2024.
  • Over 5 years, EPS (Basic) stood at -$0.38 in 2022, then increased by 27.75% to -$0.28 in 2023, then slipped by 9.58% to -$0.3 in 2024, then rose by 17.73% to -$0.25 in 2025, then grew by 18.39% to -$0.2 in 2026.
  • The last three EPS (Basic) figures came in at -$0.2 (Q1 2026), -$0.25 (Q4 2025), and -$0.21 (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 4.40
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn -8.44
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 4.34
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 12.62
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 7.70
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn -1.96
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 1.23
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 0.66
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn -0.40
10 Genelux 108.17 Mn 108.17 Mn - -0.20
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.20
Dec 31, 2025 -0.25
Sep 30, 2025 -0.21
Jun 30, 2025 -0.20
Mar 31, 2025 -0.22
Dec 31, 2024 -0.30
Sep 30, 2024 -0.19
Jun 30, 2024 -0.23
Mar 31, 2024 -0.29
Dec 31, 2023 -0.28
Sep 30, 2023 -0.20
Jun 30, 2023 -0.22
Mar 31, 2023 -0.49
Dec 31, 2022 -0.38
Sep 30, 2022 0.54